Ingevity Corporation
NYSE:NGVTChemicals - Specialty
+$0.81 today
- Market cap
- $1.97B
- Beta
- 1.19
- P/E (TTM)
- -20.0
- EPS (TTM)
- -$3.62
Volume 0.37M
Average 0.26M
NGVT Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Ingevity CorporationNYSE: NGVT
Net Receivables · Q3 FY2026 · quarter ended Sep 2026
Net receivables falls 8.2% from a year ago
Net receivables stood at $154.3M at the end of Q3 FY2026, down 8.2% from a year earlier and down 1.0% from the prior quarter. Over 3 fiscal years it compounded at -14.1% a year.
Context
- Net receivables amounted to 10.3% of total assets at the end of Q3 FY2026, up 1.1 pp from a year earlier.
- Net receivables increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether net receivables keeps falling in the next quarterly balance sheet after a -8.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 157.8M USD
- Year-over-year change
- -3.0%
- 4-year CAGR
- -4.7%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 157.8M | -3.0% |
| FY2024 | 2024-12-31 | 162.7M | -22.9% |
| FY2023 | 2023-12-31 | 211M | -15.4% |
| FY2022 | 2022-12-31 | 249.3M | +30.3% |
| FY2021 | 2021-12-31 | 191.4M | — |
Net Receivables vs competitors
How NGVT compares with its peers on the latest reported figures
- Peers report in different currencies, so net receivables is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -8.2% is the 9th highest of 11, against a peer median of +6.8%.
- Net receivables amounts to 10.3% of total assets for NGVT, versus a peer median of 12.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $2.24B USD | -22.6% | -12.2% | 23.8% | |
| Jun 2026 | $988.6M USD | -7.9% | -2.0% | 13.3% | |
| Jun 2026 | $907M USD | -5.4% | +2.7% | 12.7% | |
| Sep 2026 | $487.96M USD | +11.9% | -4.1% | 16.7% | |
| Apr 2026 | $412.7M USD | +1.7% | -0.3% | 11.9% | |
| Jun 2026 | $408.6M USD | +21.6% | +0.8% | 22.1% | |
| Jun 2026 | $256M USD | +27.4% | -15.6% | 5.6% | |
| Sep 2026 | $154.3M USD | -8.2% | -14.1% | 10.3% | |
AAUCAllied Gold Corporation | Jun 2026 | $102.26M USD | +204.5% | +25.0% | 4.6% |
ELVRElevra Lithium Limited | Jun 2026 | A$81.48M AUD | +145.2% | +61.6% | 6.0% |
| Sep 2026 | CA$8.6M CAD | -10.5% | — | 0.4% | |
| Peer median (excluding NGVT) | — | +6.8% | -0.3% | 12.3% | |
Competitors are the stored peer set for NGVT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 275.4M | 76.7M | 95.9M | 68M | 78.1M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 191.4M | 249.3M | 211M | 162.7M | 157.8M |
| Inventory | 241.2M | 335M | 308.8M | 195.9M | 186M |
| Other Current Assets | 7.1M | 12.5M | 33.4M | 58.8M | 23.6M |
| Total Current Assets | 724.9M | 683.3M | 658.6M | 493.2M | 454.2M |
| Property, Plant & Equipment (Net) | 772.1M | 855.2M | 829.3M | 687.6M | 637.6M |
| Goodwill | 442M | 518.5M | 527.5M | 175.2M | 4.3M |
| Intangible Assets | 378.7M | 455.8M | 385.3M | 323.9M | 215.5M |
| Long-term Investments | 35.3M | 109.8M | 99.2M | 87.3M | 83.1M |
| Tax Assets | 6.8M | 5.7M | 11.6M | 117.9M | 117M |
| Other Non-current Assets | 109.2M | 108.2M | 111.8M | 137.5M | 139.4M |
| Total Non-current Assets | 1.74B | 2.05B | 1.96B | 1.53B | 1.2B |
| Total Assets | 2.47B | 2.74B | 2.62B | 2.02B | 1.65B |
| Account Payables | 125.8M | 174.8M | 158.4M | 94.5M | 92M |
| Short-term Debt | 19.6M | 900K | 84.4M | 61.3M | 47.1M |
| Tax Payables | 14.4M | 8.9M | 16.7M | 5.6M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.1M | 6.9M | 15.1M | 500K | 14.7M |
| Total Current Liabilities | 268.9M | 303.5M | 362.9M | 264.1M | 341.3M |
| Long-term Debt | 1.25B | 1.47B | 1.38B | 1.24B | 1.06B |
| Deferred Tax Liabilities | 114.6M | 106.5M | 70.9M | 56.2M | 57.3M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 125.5M | 114.9M | 126.7M | 130.6M | 39M |
| Total Non-current Liabilities | 1.53B | 1.73B | 1.63B | 1.56B | 1.28B |
| Total Liabilities | 1.8B | 2.04B | 1.99B | 1.83B | 1.62B |
| Common Stock | 400K | 400K | 400K | 400K | 400K |
| Retained Earnings | 796.1M | 1.01B | 1B | 572M | 404.9M |
| Accumulated OCI | 13.1M | (46.8M) | (26.7M) | (41.4M) | 500K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 673.8M | 698.3M | 631.4M | 195.2M | 29.7M |
| Total Debt | 1.32B | 1.53B | 1.53B | 1.45B | 1.24B |
| Net Debt | 1.05B | 1.45B | 1.44B | 1.39B | 1.16B |
Ingevity Corporation
NYSE:NGVT
Intrinsic Alpha fair value
Locked
Current Price
$58.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.